The goal of OOCYSTOP is based on an innovative concept to block malaria transmission by development of new drugs that will be delivered (1) to oocysts in infected mosquitoes and (2) to early stages in human infection by the sporozoite
ORGANISM(S): Plasmodium Berghei Anka (ncbitaxon:5823)
